Aug 012023
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Xdemvy | lotilaner | 7/25/2023 | To treat Demodex blepharitis | ||
| Vanflyta | quizartinib | 7/20/2023 | To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria | Drug Trials Snapshot | |
| Beyfortus | nirsevimab-alip | 7/17/2023 | To prevent respiratory syncytial virus (RSV) lower respiratory tract disease | Press Release | Drug Trials Snapshot |
Sorry, the comment form is closed at this time.